Tennessee Oncology Nashville — Nashville, Tennessee

Tennessee Oncology Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology Nashville has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: Breast Cancer, Solid Tumors, Adult, Advanced Breast Cancer.

Sponsors: Eli Lilly and Company, Jacobio Pharmaceuticals Co., Ltd., Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology Nashville?

Tennessee Oncology Nashville has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology Nashville conducted?

Tennessee Oncology Nashville has 7 clinical trials on record, with 4 currently active. Their work covers Breast Cancer, Solid Tumors, Adult, Advanced Breast Cancer.

Is Tennessee Oncology Nashville accredited by Crixeo Health?

Tennessee Oncology Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.